Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
1.030
-0.030 (-2.83%)
Jun 6, 2025, 4:08 PM HKT
HKG:0460 Revenue
In the year 2024, Sihuan Pharmaceutical Holdings Group had annual revenue of 1.90B CNY with 2.18% growth. Sihuan Pharmaceutical Holdings Group had revenue of 951.41M in the half year ending December 31, 2024.
Revenue
1.90B CNY
Revenue Growth
+2.18%
P/S Ratio
4.66
Revenue / Employee
712.83K CNY
Employees
2,667
Market Cap
9.42B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.90B | 40.57M | 2.18% |
Dec 31, 2023 | 1.86B | -320.65M | -14.70% |
Dec 31, 2022 | 2.18B | -857.20M | -28.21% |
Dec 31, 2021 | 3.04B | 574.17M | 23.30% |
Dec 31, 2020 | 2.46B | -414.09M | -14.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
CSPC Pharmaceutical Group | 28.99B |
WuXi Biologics | 19.87B |
Sino Biopharmaceutical | 30.72B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |